In the province of Ontario there are scores of cancer patients who cannot access these potentially lifesaving scans. Why? Because the government has put a pricetag on the lives of Ontarians. And it's less than the cost of PET.Read the facts
Cancer is the leading cause of premature death in Canadians, and the number of cases will increase each year as the population grows and ages. Positron emission tomography (PET) is a medical imaging technique that is used to visualize metabolic processes in the body. When properly implemented PET is both a clinically- and cost-effective diagnostic modality for cancer, and has a significant influence on the management strategies of patients. PET is the world standard for cancer imaging and management. Canada lags behind virtually every developed nation in the world in its adoption of PET and other diagnostic technologies and the province of Ontario in particular has restricted patient access to PET for the last 15 years.
PET clinical trials have been accused of violating fundamental research ethics by using imaging and data analysis techniques incapable of detecting potential metastatic disease and thus unsuitable for the purposes of the trials. This exemplifies measures taken by the province to delay PET access for Ontario cancer patients.
The Ministry of Health has been accused of deliberately structuring clinical research protocols that would present PET in a negative light to further delay its introduction to Ontario cancer patients. Meanwhile PET imaging had already been approved in the United States and United Kingdom for multiple forms of cancer.
Ontario's illogical PET guidelines expose lung cancer patients to high risk chest needle biopsies before they can be even considered a candidate for a PET scan. This potentially harmful procedure can result in collapsed lungs or bleeding that can lead to hospitalization and immediate surgery to control bleeding.
Learn about PET, it's role in cancer detection and management, and how your elected Ontario goverment, past and present, is failing health care.
Positron emission tomography (PET) is a non-invasive medical imaging technique that is used to observe metabolic processes in the body.
PET is widely used in clinical oncology. Cancer cells exhibit high metabolic activity and can be easily imaged by their uptake of tracer molecules.